Skip to Content

Clear Blemish Treatment Jafra

Medically reviewed on March 22, 2018

Dosage form: gel
Ingredients: SALICYLIC ACID 2g in 151mL
Labeler: JAFRA COSMETICS INTERNATIONAL
NDC Code: 68828-129

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Clear Blemish Treatment

Active ingredient Purpose

Salicylic Acid 2% Acne treatment Gel

Uses

treats acne

dries up acne pimples

helps prevent new acne pimples

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

When using this product

using other topical acne medication at the same time or immediately following the use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.

Warnings

For external use only

Directions

Clean the skin thoroughly before applying.

Cover the entire affected area with a thin layer 1 to 3 times daily.

Avoid contact with eyes

Because excessive drying of the skin may occur start with 1 application daily, then gradually increase to 2 or 3 times daily.

If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive Ingredients: Acrylates/C10-30 Alkyl acrylate Crosspolymer, Aloe Barbadensis Leaf Extract, Denatonium Benzoate, Disodium Phosphate, Ethoxydiglycol, Eugenia Caryophyllus (clove) Leaf Oil, Lavandula Angustifolia (Lavender) Oil, Melia Azadirachta Extract, Panthenol, PPG-5 Ceteth-20, Propylene Glycol, Saccharide Isomerate, Salvia Sclarea (Clary) Oil, SD Alcohol 40-B/Alcohol Denat, Colloidal Sulfur, Water/Aqua, Xanthan Gum, Yeast Extract.

Clear Blemish Treatment

Gel Facial De Control Expecializado

15 ml .5 Fl Oz US

CLEAR BLEMISH TREATMENT  JAFRA
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68828-129
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID2 g  in 151 mL
Inactive Ingredients
Ingredient NameStrength
CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) 
ALOE VERA LEAF 
DENATONIUM BENZOATE 
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 
DIETHYLENE GLYCOL MONOETHYL ETHER 
CLOVE LEAF OIL 
LAVENDER OIL 
AZADIRACHTA INDICA BARK 
PANTHENOL 
PPG-5-CETETH-20 
PROPYLENE GLYCOL 
SACCHARIDE ISOMERATE 
CLARY SAGE OIL 
XANTHAN GUM 
YEAST 
Packaging
#Item CodePackage Description
1NDC:68828-129-021 TUBE in 1 BOX
1NDC:68828-129-0115 mL in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H06/19/2012
Labeler - JAFRA COSMETICS INTERNATIONAL (041676479)
Registrant - JAFRA COSMETICS INTERNATIONAL (041676479)
Establishment
NameAddressID/FEIOperations
Jafra Manufacturing, S.A. de C.V.814732061manufacture(68828-129)

 
JAFRA COSMETICS INTERNATIONAL

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide